Heron Therapeutics | HRTX - Market Capitalization


Heron Therapeutics reported $136.3M in Market Capitalization this April of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
ALKERMES USD 4.62B 333M Dec/2025
Alnylam Pharmaceuticals USD 52.54B 7.24B Dec/2025
Amarin USD 290M 51M Dec/2025
ANI Pharmaceuticals USD 1.77B 269M Dec/2025
Anika Therapeutics USD 139M 3M Dec/2025
Arrowhead Research USD 9.02B 4.25B Dec/2025
Eisai JPY 1.31T 140.95B Dec/2025
Emergent BioSolutions USD 125M 51M Dec/2023
Esperion Therapeutics USD 885M 351M Dec/2025
GlaxoSmithKline GBP 74.36B 10.31B Dec/2025
Heron Therapeutics USD 238M 7M Dec/2025
Insmed USD 37.12B 6.68B Dec/2025
Merck USD 261.26B 51.62B Dec/2025
Nektar Therapeutics USD 14.34B 13.48B Apr/2026
Neurocrine Biosciences USD 14.14B 218M Dec/2025
Pacira USD 1.06B 94M Dec/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Ultragenyx Pharmaceutical USD 2.22B 680M Dec/2025
Veracyte USD 3.33B 627M Dec/2025
Vertex Pharmaceuticals USD 115.03B 14.61B Dec/2025